Skip to main content
Covering the operations of the oil and gas industry
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Iran war
Contact
About Us
Subscribe
Newsletters
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Aelis Farma
Recent news which mentions Aelis Farma
After Four Weeks, New Drug Shows Promising Results In Boosting Life Skills For Down Syndrome Patients
November 20, 2024
Tickers
NEWS
Tags
Benzinga
Market News
Torre Fornell
From
Benzinga
French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
September 04, 2024
Tickers
CDU
INDV
NEWS
Tags
INDV
News
CDU
From
Benzinga
Study Reveals Groundbreaking Treatment For Cannabis Use Disorder With A New Class Of Medication
June 09, 2023
Tags
Markets
cannabis use disorder
Benzinga
From
Benzinga
Aelis Farma's Drug Candidate For the Treatment Of Cognitive Disorders Authorized For The First Trial In People With Down Syndrome
November 17, 2022
Tags
premium
Markets
AEMPS
From
Benzinga
Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds
June 01, 2022
Tickers
INVVY
Tags
Christian Heidbreder
Markets
News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.